Electrochemiluminescence method [Bioanalytics]

posted by Ohlbe – France, 2014-07-03 14:08 (3979 d 12:16 ago) – Posting: # 13210
Views: 3,397

Dear Avinash,

❝ The method was fully validated by manufacturer.


For patient follow-up, not for BE trials...

❝ Please suggest what would be the additional validation parameters that need to be performed to support the FDA method validation requirement?


Do your homework: read the draft FDA guidance on bioanalytical method validation, section C, particularly lines 853 to 883. This is just a draft, but I think it provides a good "suggestion".

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
24 visitors (0 registered, 24 guests [including 10 identified bots]).
Forum time: 02:24 CEST (Europe/Vienna)

Far better an approximate answer to the right question,
which is often vague, than an exact answer to the wrong question,
which can always be made precise.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5